AAAAAA

   
Results: 1-25 |
Results: 25
Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization
Authors: Stadler, WM Steinberg, G Yang, XM Hagos, F Turner, C Olopade, OI
Citation: Wm. Stadler et al., Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization, CLIN CANC R, 7(6), 2001, pp. 1676-1682
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives
Authors: Runnebaum, IB Wang-Gohrke, S Vesprini, D Kreienberg, R Lynch, H Moslehi, R Ghadirian, P Weber, B Godwin, AK Risch, H Garber, J Lerman, C Olopade, OI Foulkes, WD Karlan, B Warner, E Rosen, B Rebbeck, T Tonin, P Dube, MP Kieback, DG Narod, SA
Citation: Ib. Runnebaum et al., Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives, PHARMACOGEN, 11(7), 2001, pp. 635-638
A case of pulmonary toxicity associated with G-CSF and doxorubicin administration
Authors: Eisenbeis, CF Winn, D Poelman, S Polsky, CV Rubenstein, JH Olopade, OI
Citation: Cf. Eisenbeis et al., A case of pulmonary toxicity associated with G-CSF and doxorubicin administration, ANN HEMATOL, 80(2), 2001, pp. 121-123
Cancer genetics in oncology practice
Authors: Olopade, OI Pichert, G
Citation: Oi. Olopade et G. Pichert, Cancer genetics in oncology practice, ANN ONCOL, 12(7), 2001, pp. 895-908
Msk of breast and ovarian cancer in women with strong family histories - The Srivastava/McKinnon/Wood article reviewed
Authors: Godley, LA Olopade, OI
Citation: La. Godley et Oi. Olopade, Msk of breast and ovarian cancer in women with strong family histories - The Srivastava/McKinnon/Wood article reviewed, ONCOLOGY-NY, 15(7), 2001, pp. 906
Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer
Authors: Gao, Q Tomlinson, G Das, S Cummings, S Sveen, L Fackenthal, J Schumm, P Olopade, OI
Citation: Q. Gao et al., Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer, HUM GENET, 109(2), 2001, pp. 239-240
Identification of a 1.2 Kb cDNA fragment from a region on 9p21 commonly deleted in multiple tumor types
Authors: Gursky, S Olopade, OI Rowley, JD
Citation: S. Gursky et al., Identification of a 1.2 Kb cDNA fragment from a region on 9p21 commonly deleted in multiple tumor types, CANC GENET, 129(2), 2001, pp. 93-101
Gene-expression profiles in hereditary breast cancer (vol 344, pg 2029, 2001)
Authors: Olopade, OI
Citation: Oi. Olopade, Gene-expression profiles in hereditary breast cancer (vol 344, pg 2029, 2001), N ENG J MED, 345(8), 2001, pp. 628-628
Gene-expression profiles in hereditary breast cancer
Authors: Olopade, OI Grushko, T
Citation: Oi. Olopade et T. Grushko, Gene-expression profiles in hereditary breast cancer, N ENG J MED, 344(26), 2001, pp. 2028-2029
Male breast cancer in Cowden syndrome patients with germline PTEN mutations
Authors: Fackenthal, JD Marsh, DJ Richardson, AL Cummings, SA Eng, C Robinson, BG Olopade, OI
Citation: Jd. Fackenthal et al., Male breast cancer in Cowden syndrome patients with germline PTEN mutations, J MED GENET, 38(3), 2001, pp. 159-164
Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (oltipraz) in patients with previously resected colon polyps and first-degree female relatives of breast cancer patients
Authors: Benson, AB Olopade, OI Ratain, MJ Rademaker, A Mobarhan, S Stucky-Marshall, L French, S Dolan, ME
Citation: Ab. Benson et al., Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (oltipraz) in patients with previously resected colon polyps and first-degree female relatives of breast cancer patients, CLIN CANC R, 6(10), 2000, pp. 3870-3877
Human breast cancer susceptibility to paclitaxel therapy is independent ofBcl-2 expression
Authors: Poelman, SM Adeyanju, MO Robertson, MA Recant, WM Karrison, T Fleming, GF Olopade, OI Conzen, SD
Citation: Sm. Poelman et al., Human breast cancer susceptibility to paclitaxel therapy is independent ofBcl-2 expression, CLIN CANC R, 6(10), 2000, pp. 4043-4048
Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q
Authors: Gao, Q Horwitz, M Roulston, D Hagos, F Zhao, ND Freireich, EJ Golomb, HM Olopade, OI
Citation: Q. Gao et al., Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q, GENE CHROM, 28(2), 2000, pp. 164-172
Breast cancer genetics - Implications for clinical practice
Authors: Olopade, OI Fackenthal, JD
Citation: Oi. Olopade et Jd. Fackenthal, Breast cancer genetics - Implications for clinical practice, HEMAT ONCOL, 14(3), 2000, pp. 705
Genetic testing of African Americans for susceptibility to inherited cancers: Use of focus groups to determine factors contributing to participation
Authors: Matthews, AK Cummings, S Thompson, S Wohl, V List, M Olopade, OI
Citation: Ak. Matthews et al., Genetic testing of African Americans for susceptibility to inherited cancers: Use of focus groups to determine factors contributing to participation, J PSYCH ONC, 18(2), 2000, pp. 1-19
Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations
Authors: Pierce, LJ Strawderman, M Narod, SA Oliviotto, I Eisen, A Dawson, L Gaffney, D Solin, LJ Nixon, A Garber, J Berg, C Isaacs, C Heimann, R Olopade, OI Haffty, B Weber, BL
Citation: Lj. Pierce et al., Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations, J CL ONCOL, 18(19), 2000, pp. 3360-3369
Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer
Authors: Gao, Q Tomlinson, G Das, S Cummings, S Sveen, L Fackenthal, J Schumm, P Olopade, OI
Citation: Q. Gao et al., Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer, HUM GENET, 107(2), 2000, pp. 186-191
Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer
Authors: Gao, Q Adebamowo, CA Fackenthal, J Das, S Sveen, L Falusi, AG Olopade, OI
Citation: Q. Gao et al., Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer, HUM GENET, 107(2), 2000, pp. 192-194
Computerized analysis of mammographic parenchymal patterns for breast cancer risk assessment: Feature selection
Authors: Huo, ZM Giger, ML Wolverton, DE Zhong, WM Cumming, S Olopade, OI
Citation: Zm. Huo et al., Computerized analysis of mammographic parenchymal patterns for breast cancer risk assessment: Feature selection, MED PHYS, 27(1), 2000, pp. 4-12
Evidence of a founder BRCA1 mutation in Scotland
Authors: Liede, A Cohen, B Black, DM Davidson, RH Renwick, A Hoodfar, E Olopade, OI Micek, M Anderson, V De Mey, R Fordyce, A Warner, E Dann, JL King, MC Weber, B Narod, SA Steel, CM
Citation: A. Liede et al., Evidence of a founder BRCA1 mutation in Scotland, BR J CANC, 82(3), 2000, pp. 705-711
Lack of evidence for a polymorphism at codon 160 of human O-6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer
Authors: Wu, MH Lohrbach, KE Olopade, OI Kokkinakis, DM Friedman, HS Dolan, ME
Citation: Mh. Wu et al., Lack of evidence for a polymorphism at codon 160 of human O-6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer, CLIN CANC R, 5(1), 1999, pp. 209-213
Assessing hereditary breast cancer risk
Authors: Goetsch, CM Smith, SM Olopade, OI Nagel, HL Ledbetter, N Wool, MS
Citation: Cm. Goetsch et al., Assessing hereditary breast cancer risk, CANCER PRAC, 7(6), 1999, pp. 279-284
Therapeutic plasma exchange for the acute management of the catastrophic antiphospholipid syndrome: beta(2)-glycoprotein I antibodies as a marker of response to therapy
Authors: Flamholz, R Tran, T Grad, GI Mauer, AM Olopade, OI Ellman, MH McKinsey, JF Jeon, HR Baron, JM Baron, BW
Citation: R. Flamholz et al., Therapeutic plasma exchange for the acute management of the catastrophic antiphospholipid syndrome: beta(2)-glycoprotein I antibodies as a marker of response to therapy, J CLIN APH, 14(4), 1999, pp. 171-176
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2
Authors: Jernstrom, H Lerman, C Ghadirian, P Lynch, HT Weber, B Garber, J Daly, M Olopade, OI Foulkes, WD Warner, E Brunet, JS Narod, SA
Citation: H. Jernstrom et al., Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2, LANCET, 354(9193), 1999, pp. 1846-1850
Pathogenesis of early leukemia and lymphoma
Authors: Finiewicz, KJ Olopade, OI
Citation: Kj. Finiewicz et Oi. Olopade, Pathogenesis of early leukemia and lymphoma, MOLECULAR PATHOLOGY OF EARLY CANCER, 1999, pp. 233-253
Risultati: 1-25 |